.
Health

The Heart of Our Breed

"Ongoing Studies"

 .
.
.
.
 
Library
CHIC - How & Why
CHIC Yorkies
Fund Raising 
Screening Clinics
Ongoing Studies
,Grants
.
,Links

<<<<<<<<<<<<<<<<<<<<>>>>>>>>>>>>>>>>>>>>>>>

RESEARCH UPDATE FROM DR. CENTER


5/12/10

Reprinted with permission from Jean Vore, Morris Animal Foundation

YTCA Health Committee

 

D08CA-001

Genetics of Portosystemic Vascular Anomalies and Microvascular Dysplasia in Small Breed Dogs 

Cornell University

Sharon A. Center, DVM, DACVIM

 

Portosystemic vascular anomalies (PSVAs) and microvascular dysplasia (MVD) are related genetic disorders that cause abnormal liver circulation in small terrier breeds of dogs. The prevalence ranges from 30 to 80 percent. Many dogs with PSVA are overtly ill because the liver cannot remove toxins from food. Dogs with MVD, on the other hand, may only demonstrate intolerance to standard drug dosages. In the first phase of the study, researchers from Cornell University prepared DNA from 44 Cairn terriers (22 dogs affected with PSVA and 22 matched unaffected sibling controls) and 22 dogs (11 affected and 11 unaffected sibling controls) from four additional breeds—Yorkshire terriers, Tibetan spaniels, Maltese and Norfolk terriers—for genotyping analysis. There have been some delays due to a robotic malfunction in the genomic analysis instrumentation, which required some DNA samples to be resubmitted for analysis.  Using the incomplete data set, the researchers were able to identify four regions of interest on three different chromosomes. Once the full data set becomes available later this summer, the researchers will begin fine-mapping these chromosomal regions in hopes of further narrowing the regions of interest. The investigators are also continuing their overlap analysis, comparing results of two different genomic analysis techniques on samples from affected and unaffected Cairn terriers and Tibetan spaniels. Candidate genes identified by overlap analysis will be sequenced to identify potential genetic mutations. To date, the investigators have completed the sequencing of three candidate genes; however, none of these genes was found to be responsible for PSVA or MVD. Once genetic mutations responsible for these abnormalities are identified, the investigators plan to develop affordable genetic tests that can identify carrier animals. These tests would be used to make breeding decisions that would reduce and eventually eliminate the occurrence of these liver disorders in these breeds. The study is also providing a research associate and an assistant professor, both of whom are in the early stages of their scientific careers, with valuable training in veterinary molecular genetics and in the mapping of complex traits.

<<<<<<<<<<<<<<<<<<<<>>>>>>>>>>>>>>>>>>>>>>>

 
  Click here for a new message from Dr. Center 



Click here for Questions for Dr. Center.
 Yorkshire Terrier Club of America. Memphis, Oct. 30, 2009


 <<<<<<<<<<<<<<<<<<<<>>>>>>>>>>>>>>>>>>>>>>>
.

Dear club members,
I am Dr. Susana Mendez, from the J.A. Baker Institute for Animal Health, at the Cornell Veterinary College, Ithaca, NY. One of my research lines is dedicated to Leishmania infections, with the final aim of developing a vaccine.
Read my article by clicking here! 
.
.
<<<<<<<<<<<<<<<<<<<<>>>>>>>>>>>>>>>>>>>>>>>

.

    PRA

Dear Ms. Bedsted, 

I am writing to you because I see on the YTCA website that you are the chairperson of the YTCA health committee. I want to let you know of a finding that we have made recently at OptiGen through our research/free testing program. 

A Yorkshire Terrier that was diagnosed with Progressive Retinal Atrophy (PRA) was sent to us for free testing and we have found that the cause of that PRA is prcd-PRA.  This particular Yorkshire comes from a line of champions and so I am concerned that prcd-PRA may be present to a significant extent in the breed.  I have spoken with the owners of the affected dog to let them know that we will add Yorkshire Terriers to the list of breeds that can make use of OptiGen DNA testing. 

This will allow them to test their line for any Carriers and to prevent the production of any prcd-Affected offspring in their future breedings. In looking at the CERF statistics, I see the PRA is not that uncommon in Yorkshires --2-4% of the Yorkshires that were examined between 2000-2005 were diagnosed with PRA. 

Although it is never a happy day when a hereditary disease is identified in one's beloved breed, I am hopeful that breeders will recognize what a great advantage it is to have a DNA test immediately available to detect any carriers of the disease in the population.  There is information on our website about prcd 
http://www.optigen.com/opt9_test_prcd_pra.html

Also, I would be very happy to answer any questions or discuss this finding anytime. 
Best Regards, Sue PK 

--
Sue Pearce-Kelling 
President and Manager, OptiGen, LLC 
Cornell Business & Technology Park 
767 Warren Road, Suite 300 
Ithaca, NY 14850 
www.optigen.com 
ph:  (607) 257-0301 

fax: (607) 257-0353
.
<<<<<<<<<<<<<<<<<<<<>>>>>>>>>>>>>>>>>>>>>>>
.
.
 .
Back to home page

.
.
.
/